Nexalin Technology (NXL) FCF Margin (QoQ) (2022 - 2026)
Nexalin Technology (NXL) FCF Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 7.08 Mn | 6.07 Mn | 8,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -302,708.00 |
| Mar 31, 2026 | -1.11 Mn |
| Dec 31, 2025 | 741,113.00 |
| Sep 30, 2025 | -677,967.00 |
| Jun 30, 2025 | 217,798.00 |
| Mar 31, 2025 | 69,679.00 |
| Dec 31, 2024 | -195,320.00 |
| Sep 30, 2024 | 242,298.00 |
| Jun 30, 2024 | -367,364.00 |
| Mar 31, 2024 | 391,889.00 |
| Dec 31, 2023 | -198,159.00 |
| Sep 30, 2023 | -61,263.00 |
| Jun 30, 2023 | 200,695.00 |
| Mar 31, 2023 | -194,277.00 |
| Dec 31, 2022 | -218,604.00 |
| Sep 30, 2022 | -13,388.00 |
| Jun 30, 2022 | 2,370.00 |
| Mar 31, 2022 | 164,175.00 |